Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research, and Coronary Interventions and Diagnostics.
Prognostic Impact of Carvedilol vs. Metoprolol on Long-Term Outcomes in Patients with Heart Failure and Mildly Reduced Ejection Fraction.
Overall coronary disease burden modifies the prognostic benefit of CTO-PCI: a SYNTAX score-stratified meta-analysis.
Timing of ECLS Initiation and Outcomes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Predefined Subanalysis of the ECLS-SHOCK Trial.
Mechanical circulatory support center volume and outcomes in infarct-related cardiogenic shock: the ECLS-SHOCK trial.
Prognostic Implications of Sex in Patients With Heart Failure With Mildly Reduced Ejection Fraction: Results From a Large-Scaled Registry.
Age-Related Outcomes in Patients Undergoing Coronary Angiography: In Which Subgroups Does Age Matter? Results from a Large-Scale Retrospective Registry.
Prevalence and Prognostic Impact of Coronary Chronic Total Occlusions in Patients With Cardiogenic Shock.
COVID-19 and Myocarditis: Trends, Clinical Characteristics, and Future Directions.
Sex-Based Differences and Outcomes in Unselected Patients Undergoing Coronary Angiography.
Coronary Chronic Total Occlusions Affect Long-Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction.
Left Ventricular Ejection Fraction Predicts Outcomes in Different Subgroups of Patients Undergoing Coronary Angiography.
The Prognostic Impact of Kidney Dysfunction in Unselected Patients Undergoing Coronary Angiography: In What Subgroups Does Kidney Dysfunction Matter?
Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
Diagnostic and Prognostic Value of Aminoterminal Prohormone of Brain Natriuretic Peptide in Heart Failure with Mildly Reduced Ejection Fraction Stratified by the Degree of Renal Dysfunction.
Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction.
Prognostic Implications of Type 2 Diabetes Mellitus in Heart Failure with Mildly Reduced Ejection Fraction.
Prognostic Implications of Septal Hypertrophy in Patients with Heart Failure with Mildly Reduced Ejection Fraction.
Prognostic Impact of Anemia and Hemoglobin Levels in Unselected Patients Undergoing Coronary Angiography.
Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection Fraction.
Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock.
Does Albumin Predict the Risk of Mortality in Patients with Cardiogenic Shock?
Acute oesophageal safety and long-term follow-up of AI-guided high-power short-duration with 50 W for atrial fibrillation ablation.
Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock.
Safety and Efficiency of Rotational Atherectomy in Chronic Total Coronary Occlusion-One-Year Clinical Outcomes of an Observational Registry.
Electrical Storm Has Worse Prognosis Compared to Sustained Ventricular Tachycardia after VT Ablation.
Differences in Outcome of Patients with Cardiogenic Shock Associated with In-Hospital or Out-of-Hospital Cardiac Arrest.
Prognostic Value of the AST/ALT Ratio versus Bilirubin in Patients with Cardiogenic Shock.
Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention.
Effect of Cardiovascular Risk Factors on 30-Day All-Cause Mortality in Cardiogenic Shock.